Related Experiment Video
Updated: Sep 16, 2025

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
CAR-Based Cell Therapy in Head and Neck Cancer: A Comprehensive Review on Clinical Applicability
Francesco Perri1, Margaret Ottaviano2, Miriam Tomaciello3
1Clinical and Experimental Head and Neck Medical Oncology Unit, INT IRCCS Foundation G Pascale, 80131 Naples, Italy.
Chimeric antigen receptor T-cell (CAR-T) therapy shows promise for head and neck cancer (HNC). Despite challenges in the immunosuppressive tumor microenvironment, CAR-T cell therapy may offer future clinical applications for HNC management.
Area of Science:
- Immunotherapy
- Oncology
- Cellular Therapy
Background:
- Chimeric antigen receptor T-cell (CAR-T) therapy is a novel immunotherapy.
- CAR-T therapy is effective in hematologic malignancies but limited in solid tumors.
- Head and neck cancer (HNC) presents unique diagnostic and therapeutic challenges.
Purpose of the Study:
- To explore the rationale for developing adoptive cellular therapies in HNC.
- To provide insights into diagnostic and therapeutic challenges in HNC.
- To review the application of CAR-T cell therapy in HNC management.
Main Methods:
- Comprehensive literature review.
- PubMed database search for relevant studies.
- Focus on CAR-T cell therapy in HNC.
Main Results:
- HNC tumor microenvironment (TME) poses barriers to CAR-T cell infiltration.
- HNC TME is immunosuppressive, with regulatory T cells (Tregs) and natural killer (NK) cells.
- Low CD16 receptor expression on immune cells limits antibody-dependent cellular cytotoxicity (ADCC).
Conclusions:
- CAR-T therapy has potential clinical applicability in HNC.
- Overcoming TME challenges is crucial for CAR-T efficacy in HNC.
- Further research is warranted for CAR-T application in HNC.
More Related Videos
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
05:22Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice
Published on: February 24, 2023
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers